The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
In vitro and in vivo experimental models for drug screening and development for Chagas disease
Open accessAbstract
Chagas disease, a neglected illness, affects nearly 12-14 million people in endemic areas of Latin America. Although the occurrence of acute cases sharply has declined due to Southern Cone Initiative efforts to control vector transmission, there still remain serious challenges, including the maintenance of sustainable public policies for Chagas disease control and the urgent need for better drugs to treat chagasic patients. Since the introduction of benznidazole and nifurtimox approximately 40 years ago, many natural and synthetic compounds have been assayed against Trypanosoma cruzi, yet only a few compounds have advanced to clinical trials. This reflects, at least in part, the lack of consensus regarding appropriate in vitro and in vivo screening protocols as well as the lack of biomarkers for treating parasitaemia. The development of more effective drugs requires (i) the identification and validation of parasite targets, (ii) compounds to be screened against the targets or the whole parasite and (iii) a panel of minimum standardised procedures to advance leading compounds to clinical trials. This third aim was the topic of the workshop entitled Experimental Models in Drug Screening and Development for Chagas Disease, held in Rio de Janeiro, Brazil, on the 25th and 26th of November 2008 by the Fiocruz Program for Research and Technological Development on Chagas Disease and Drugs for Neglected Diseases Initiative. During the meeting, the minimum steps, requirements and decision gates for the determination of the efficacy of novel drugs for T. cruzi control were evaluated by interdisciplinary experts and an in vitro and in vivo flowchart was designed to serve as a general and standardised protocol for screening potential drugs for the treatment of Chagas disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zingales, B. S., Sg, A., Briones, M. R. S., Campbell, D. M., Chiari, E., Fernandes, O., Guhl, F., Lages‐Silva, E., Macedo, A. A. P., Machado, C. R., et al. (2009) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762009000700021 · Cited by 1,050
Self-citationA Critical Review on Chagas Disease Chemotherapy
Coura, J. R., & Castro, S. L. D. (2002) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762002000100001 · Cited by 1,003
Self-citationTherapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi.
Brener, Z. Z. (1962) · PubMed · Cited by 789
Innovative lead discovery strategies for tropical diseases
Nwaka, S., & Hudson, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2144 · Cited by 521
Filardi, L. S., & Brener, Z. (1987) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(87)90020-4 · Cited by 497
Walum, E. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106497 · Cited by 379
Bustamante, J. M., Bixby, L. M., & Tarleton, R. L. (2008) · Nature Medicine · doi:10.1038/nm1744 · Cited by 194
Self-citationTwo approaches to discovering and developing new drugs for Chagas disease
McKerrow, J., Doyle, P., Engel, J., Podust, L., Robertson, S., Ferreira, R., Saxton, T., Arkin, M., Kerr, I., Brinen, L., et al. (2009) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762009000900034 · Cited by 177
An update on the management of Chagas cardiomyopathy
Rocha, M. O., Teixeira, M. M., & Ribeiro, A. L. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.4.727 · Cited by 158
Bettiol, E., Samanovic, M. I., Murkin, A. S., Raper, J., C, F. S. B. A., & Rodríguez, A. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000384 · Cited by 91
Cited by
Vanadium compounds in medicine
Pessoa, J. C., Etcheverry, S., & Gambino, D. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.12.002 · Cited by 561
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need
Field, M. C., Horn, D., Fairlamb, A. H., Ferguson, M. A. J., Gray, D. W., Read, K. D., De Rycker, M., Torrie, L. S., Wyatt, P. G., Wyllie, S., et al. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.193 · Cited by 421
Experimental and Clinical Treatment of Chagas Disease: A Review
Sales Junior, P. A., Molina, I., Fonseca Murta, S. M., Sánchez-Montalvá, A., Salvador, F., Corrêa-Oliveira, R., & Carneiro, C. M. (2017) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0761 · Cited by 305
Gulin, J. E. N., Rocco, D. M., & García-Bournissen, F. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004194 · Cited by 66
Polyamine depletion inhibits the autophagic response modulatingTrypanosoma cruziinfectivity
Vanrell, M. C., Cueto, J. A., Barclay, J. J., Carrillo, C., Colombo, M. I., Gottlieb, R. A., & Romano, P. S. (2013) · Autophagy · doi:10.4161/auto.24709 · Cited by 39
Metadata
- Authors
- Romanha, A. J., Castro, S. L. D., Soeiro, M. D. N. C., Lannes-Vieira, J., Ribeiro, I., Talvani, A., Bourdin, B., Blum, B., Olivieri, B., Zani, C., Spadafora, C., Chiari, E., Chatelain, E., Chaves, G., Calzada, J. E., Bustamante, J. M., Freitas-Junior, L. H., Romero, L. I., Bahia, M. T., Lotrowska, M., Soares, M., Andrade, S. G., Armstrong, T., Degrave, W., & Andrade, Z. D. A.
- Venue
- Memórias do Instituto Oswaldo Cruz
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2010-03
- Volume
- 105
- Issue
- 2
- Pages
- 233-238
- ISSN
- 0074-0276 (ISSN-L)
- OpenAlex
- W2125888372
- Cited by
- 356
- References
- 11
- FWCI
- 9.64
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vitro and in vivo experimental models for drug screening and development for Chagas disease. https://app.cochat.ai/papers/10.1590/s0074-02762010000200022
- The paper
- Romanha, A. J., Castro, S. L. D., Soeiro, M. D. N. C., Lannes-Vieira, J., Ribeiro, I., Talvani, A., Bourdin, B., Blum, B., Olivieri, B., Zani, C., Spadafora, C., Chiari, E., Chatelain, E., Chaves, G., Calzada, J. E., Bustamante, J. M., Freitas-Junior, L. H., Romero, L. I., Bahia, M. T., . . . Andrade, Z. D. A. (2010). In vitro and in vivo experimental models for drug screening and development for Chagas disease. Memórias do Instituto Oswaldo Cruz. https://doi.org/10.1590/s0074-02762010000200022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.